[144] Lumentum Holdings Inc. SEC Filing

Rhea-AI Filing Summary

Lumentum Holdings Inc. (LITE) Form 144 notice shows an intended sale of 2,222 common shares through Morgan Stanley Smith Barney LLC on 08/18/2025 with an aggregate market value of $258,751.90 against total shares outstanding listed as 69,400,000. The filing reports the shares were acquired as restricted stock on 08/15/2025 from the issuer, with payment dated the same day. The filer also reported a prior sale of 2,222 common shares on 06/04/2025 generating $185,714.76 in gross proceeds. The notice includes the usual signer representation about absence of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider intends a small, routine sale of 2,222 LITE shares; transaction size is immaterial relative to outstanding shares.

The filing documents a planned sale of 2,222 common shares valued at $258,751.90, executed via Morgan Stanley Smith Barney on 08/18/2025. Against the disclosed 69.4 million shares outstanding, this represents a de minimis fraction, suggesting limited direct market impact. The filing also shows a prior sale of 2,222 shares on 06/04/2025. The shares being sold were identified as restricted stock acquired from the issuer on 08/15/2025. No earnings, debt, or operational details are provided to change fundamental credit or valuation views.

Corporate Governance Expert

TL;DR: This Form 144 is a routine disclosure; it raises standard governance transparency but no governance red flags alone.

The notice fulfills Rule 144 disclosure for an insider sale executed through an institutional broker. The representation that the signer has no undisclosed material adverse information is included, and there is a recorded recent sale in June 2025. The filing lacks details about the identity of the filer beyond address in the historical sale row and does not indicate any unusual trading plan adoption dates or reliance on Rule 10b5-1, which would typically be disclosed if applicable.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2222	258751.90	69400000	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock	ISSUER			2222	08/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
WAJID ALI 1001 Ridder Park Drive San Jose CA 95131	Common	06/04/2025	2222	185714.76

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does LITE's Form 144 disclose about the proposed sale?

The notice reports a proposed sale of 2,222 common shares on 08/18/2025 via Morgan Stanley Smith Barney LLC with aggregate market value $258,751.90.

How large is the sale relative to Lumentum's outstanding shares?

The filing lists 69,400,000 shares outstanding; the 2,222-share sale is an immaterial fraction of that total.

Were these shares recently acquired or restricted?

The securities to be sold are reported as restricted stock acquired from the issuer on 08/15/2025 with payment dated the same day.

Has the filer sold shares of LITE recently?

Yes; the filing discloses a prior sale of 2,222 common shares on 06/04/2025 for gross proceeds of $185,714.76.

Does the filing state reliance on a Rule 10b5-1 trading plan?

No plan adoption date or explicit reliance on Rule 10b5-1 is provided in the filing.